University of Miami-Jackson Health System Program

Program Identity & Fit

University of Miami/Jackson Health System is a large, academic radiation oncology program anchored at Sylvester Comprehensive Cancer Center, offering an unusually comprehensive technology platform (proton therapy, MR-LINAC, HyperArc SRS, IORT, brachytherapy, eye plaque) across public (Jackson) and private clinical partners that ensures breadth of case complexity and volume. Research is structurally embedded rather than peripheral: all residents receive 12 protected months, with a formal pathway to up to 21 months via the ABR Holman Research Pathway, a resident research retreat with visiting professors, and a required research-proposal planning process tied to long-term career goals. The current resident cohort skews heavily toward dual-degree, prior-residency-trained, and research-productive physicians (MSTP, PhD, prior neurosurgery/general surgery/internal medicine training, T32 fellowships), reflecting a program built around trainees entering with substantial prior investigative or clinical training rather than straight-through applicants. The department's scale (270+ staff, 18 treatment units) and integration with a comprehensive cancer center's clinical/physics/biology divisions signal a strong academic, subspecialized, tertiary-referral identity oriented toward producing academically-engaged radiation oncologists.